LINK:  https://bswhealth.webex.com/webappng/sites/bswhealth/meeting/info/7460991cb66d4a1f94f6ccdd096cf8b1?siteurl=bswhealth&MTID=mf11d9842cc610cc419b3aaa54a4c2014

Diseases and treatment modalities evolve and improve with research about pulmonary disease. There is a need for physicians to get together to ensure consistent, evidence-based care of patients with pulmonary diseases using the most up to date and relevant knowledge available.

OBJECTIVES:  As a result of this activity, the participant should be able to: 

1. Review the study “Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia” published 1/7/2021 in the NEJM
1. Review the pathophysiology of COVID pneumonia and cytokine overproduction
2. Discuss further pursuits in discovering therapies for management of COVID pneumonia

FACULTY DISCLOSURE:  (Jiesu Lee Sun, MD MPH) does not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. 

PLANNERS DISCLOSURES: Idrees Mogri, MD and Jennifer Hartsock-Juarez do not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. 

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of  1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information please contact: Priscilla Lima at Priscilla.Lima@BSWHealth.org